메뉴 건너뛰기




Volumn 163, Issue 5, 2013, Pages 685-687

Correlating prothrombin time with plasma rivaroxaban level

Author keywords

Anti Xa assay; Prothrombin time; Rivaroxaban

Indexed keywords

RIVAROXABAN;

EID: 84887613868     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12566     Document Type: Letter
Times cited : (13)

References (5)
  • 1
    • 84868210856 scopus 로고    scopus 로고
    • Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology
    • Baglin, T., Keeling, D. & Kitchen, S. (2012) Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology. British Journal of Haematology, 159, 427-429.
    • (2012) British Journal of Haematology , vol.159 , pp. 427-429
    • Baglin, T.1    Keeling, D.2    Kitchen, S.3
  • 2
    • 84870240173 scopus 로고    scopus 로고
    • Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendation for the monitoring of rivaroxaban and review of the literature
    • Douxfils, J., Mullier, F., Loosen, C., Chhatelain, C., Chatelain, B. & Dogne, J.M. (2012) Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendation for the monitoring of rivaroxaban and review of the literature. Thrombosis Research, 130, 956-966.
    • (2012) Thrombosis Research , vol.130 , pp. 956-966
    • Douxfils, J.1    Mullier, F.2    Loosen, C.3    Chhatelain, C.4    Chatelain, B.5    Dogne, J.M.6
  • 3
    • 80052485992 scopus 로고    scopus 로고
    • Rivaroxaban: population pharmokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention
    • Mueck, W., Lensing, A.W., Agnelli, G., Decousus, H., Prandoni, P. & Misselwitz, F. (2011) Rivaroxaban: population pharmokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clinical Pharmacokinetics, 50, 675-686.
    • (2011) Clinical Pharmacokinetics , vol.50 , pp. 675-686
    • Mueck, W.1    Lensing, A.W.2    Agnelli, G.3    Decousus, H.4    Prandoni, P.5    Misselwitz, F.6
  • 5
    • 84874716219 scopus 로고    scopus 로고
    • Normal prothrombin time in the presence of therapeutic levels of rivaroxaban
    • Van Veen, J.J., Smith, J., Kitchen, S. & Makris, M. (2013) Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. British Journal of Haematology, 160, 859-861.
    • (2013) British Journal of Haematology , vol.160 , pp. 859-861
    • Van Veen, J.J.1    Smith, J.2    Kitchen, S.3    Makris, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.